Seok Jin Kim
Seok Jin Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Verified email at skku.edu
Title
Cited by
Cited by
Year
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium…
SJ Kim, K Kim, BS Kim, CY Kim, C Suh, J Huh, SW Lee, JS Kim, J Cho, ...
3252009
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim
Blood 120 (15), 2973-2980, 2012
2962012
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
HY Yoo, MK Sung, SH Lee, S Kim, H Lee, S Park, SC Kim, B Lee, K Rho, ...
Nature genetics 46 (4), 371-375, 2014
2612014
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
YL Kwong, TSY Chan, D Tan, SJ Kim, LM Poon, B Mow, PL Khong, ...
Blood 129 (17), 2437-2442, 2017
2292017
Expression of HIF-1, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
SJ Kim, ZN Rabbani, MW Dewhirst, Z Vujaskovic, RT Vollmer, ...
Lung cancer 49 (3), 325-335, 2005
2252005
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
SJ Kim, DH Yoon, A Jaccard, WJ Chng, ST Lim, H Hong, Y Park, ...
The lancet oncology 17 (3), 389-400, 2016
1542016
Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
K Ohmachi, N Niitsu, T Uchida, SJ Kim, K Ando, N Takahashi, ...
Journal of clinical oncology 31 (17), 2103-2109, 2013
1412013
Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type
SJ Kim, BS Kim, CW Choi, J Choi, I Kim, YH Lee, JS Kim
Annals of oncology 18 (8), 1382-1387, 2007
1292007
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
SJ Kim, C Hsu, YQ Song, K Tay, XN Hong, J Cao, JS Kim, HS Eom, ...
European journal of cancer 49 (16), 3486-3496, 2013
1092013
Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group
E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ...
American journal of hematology 87 (7), 663-668, 2012
1022012
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
SJ Kim, HJ Kang, JS Kim, SY Oh, CW Choi, SI Lee, JH Won, MK Kim, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1958-1965, 2011
1012011
Carbonic Anhydrase IX in Early-Stage Non–Small Cell Lung Cancer
SJ Kim, ZN Rabbani, RT Vollmer, EG Schreiber, E Oosterwijk, ...
Clinical cancer research 10 (23), 7925-7933, 2004
1002004
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
SJ Kim, CW Choi, YC Mun, SY Oh, HJ Kang, SI Lee, JH Won, MK Kim, ...
BMC cancer 11 (1), 321, 2011
992011
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial
SJ Kim, DH Yoon, HJ Kang, JS Kim, SK Park, HJ Kim, J Lee, BY Ryoo, ...
European Journal of Cancer 48 (17), 3223-3231, 2012
972012
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
SJ Kim, JW Lee, CW Jung, CK Min, B Cho, HJ Shin, JS Chung, H Kim, ...
haematologica 95 (11), 1935-1942, 2010
932010
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
S Lee, HY Park, SY Kang, SJ Kim, J Hwang, S Lee, SH Kwak, KS Park, ...
Oncotarget 6 (19), 17764, 2015
912015
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
HY Yhim, HJ Kang, YH Choi, SJ Kim, WS Kim, YS Chae, JS Kim, CW Choi, ...
BMC cancer 10 (1), 321, 2010
812010
Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma
CO Sung, SC Kim, S Karnan, K Karube, HJ Shin, DH Nam, YL Suh, ...
Blood, The Journal of the American Society of Hematology 117 (4), 1291-1300, 2011
802011
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
SJ Kim, DH Yang, JS Kim, JY Kwak, HS Eom, DS Hong, JH Won, JH Lee, ...
Annals of hematology 93 (11), 1895-1901, 2014
782014
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
YR Kim, JS Kim, YH Min, DH Yoon, HJ Shin, YC Mun, Y Park, YR Do, ...
Journal of Hematology & Oncology 5 (1), 49, 2012
742012
The system can't perform the operation now. Try again later.
Articles 1–20